The NFL stood firmly behind the Philadelphia Eagles’ management of quarterback Jalen Hurts’s blood clot condition on Tuesday. Shortly after, the players’ union called for an inquiry into the matter. The Eagles were confirmed not to face any disciplinary action in their handling of Hurts. Dr. Allen Sills, the NFL’s chief medical officer, defended the Eagles’ approach in treating Hurts, emphasizing their cautious and patient-centered methods.
The league maintained constant communication with Philadelphia’s medical team and the Cleveland Clinic in London throughout the process. The NFL Players Association expressed the need for a thorough investigation before drawing conclusions on the situation for the benefit of players’ care and protection.
Hurts, currently on injured reserve, is expected to sit out the remainder of the season due to a blood clot in his left calf that traveled to his lungs. NFL executive vice president Jeff Miller refuted claims of Hurts going without sleep for an extended period before a game, clarifying that Hurts did rest before the match.
Dr. Caron Rockman, a veteran vascular surgeon, stated that the Eagles acted appropriately based on available information. Hurts’s treatment involves blood thinners, and he is barred from football activities until he stops taking them. Hurts played a game in London despite the injury diagnosis, with medical experts conducting advanced imaging to ensure his health and safety.
Sills emphasized that medical decisions take precedence over sports considerations and reassured that player safety is paramount in all circumstances.